Date published: 2025-11-24

00800 4573 8000

SCBT Portrait Logo
Seach Input

SIMPL Activateurs

SIMPL, which stands for Signal Integration by the Mitogen-activated Protein kinase (MAPK) Pathway, is a protein that in humans is encoded by the SIMPL gene. This protein acts as a modulator of transcriptional response within the MAPK signaling pathway, which is a critical cascade in cellular biology that transmits molecular signals from the cell membrane to the nucleus.The MAPK pathway is involved in a wide array of cellular processes, including growth, differentiation, and response to stress. It is made up of a series of kinase enzymes that activate one another in a specific sequence, leading to the phosphorylation and activation of downstream targets, including transcription factors that regulate gene expression.

SIMPL itself is not a kinase but rather a nuclear protein that interacts with the MAPK pathway components. It has been found to function as an adaptor or scaffold protein, facilitating the interaction between the MAPKs and their target transcription factors in the nucleus. Specifically, SIMPL has been shown to interact with tumor necrosis factor-alpha (TNF-alpha) and modulate the activity of transcription factor NF-kappaB, which plays a pivotal role in immune and inflammatory responses.By influencing the NF-kappaB pathway, SIMPL can impact the transcription of genes that are involved in immune and inflammatory responses, cell survival, and apoptosis. Dysregulation of NF-kappaB has been linked to various pathological conditions, including cancer, inflammatory and autoimmune diseases, and viral infections, which highlights the potential significance of SIMPL in disease processes.

VOIR ÉGALEMENT...

Nom du produitCAS #Ref. CatalogueQuantitéPrix HTCITATIONS Classement

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

Inhibiteur de la MAP kinase p38, influençant indirectement IRAK1BP1 en affectant les voies de signalisation en aval liées à l'IL-1.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

Inhibiteur de la MEK, qui peut indirectement affecter IRAK1BP1 en modulant les voies de signalisation ERK/MAPK.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

Inhibiteur de JNK, influençant potentiellement IRAK1BP1 par les voies de la protéine kinase activée par le stress.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

Un inhibiteur de PI3K, qui pourrait affecter l'activité d'IRAK1BP1 indirectement par le biais de la voie de signalisation AKT.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

Un autre inhibiteur de PI3K, modulant potentiellement IRAK1BP1 en affectant la signalisation PI3K/AKT.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

Inhibiteur de mTOR, influençant potentiellement l'activité d'IRAK1BP1 indirectement par les voies de signalisation de mTOR.